Race/Ethnicity and Protease Inhibitor Use Influence Plasma Tenofovir Exposure in Adults Living with HIV-1 in AIDS Clinical Trials Group Study A5202

AIDS Clinical Trial Group study A5202 (ClinicalTrials.gov identifier NCT00118898) was a phase 3b, randomized, partially blinded equivalence study of open-label atazanavir/ritonavir or efavirenz, plus either placebo-controlled tenofovir disoproxil fumarate/emtricitabine or abacavir/lamivudine, in tre...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Antimicrob Agents Chemother
Main Authors: Bednasz, Cindy J., Venuto, Charles S., Ma, Qing, Daar, Eric S., Sax, Paul E., Fischl, Margaret A., Collier, Ann C., Smith, Kimberly Y., Tierney, Camlin, Acosta, Edward P., Mager, Donald E., Morse, Gene D.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2019
Assuntos:
Pharmacology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6437535/
https://ncbi.nlm.nih.gov/pubmed/30642925
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01638-18
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados